Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in TaxesChange in TaxesOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Universe Pharmaceuticals (UPC) Other financing activities (2020 - 2024)

Universe Pharmaceuticals' Other financing activities history spans 5 years, with the latest figure at $29.3 million for Q1 2024.

  • On a quarterly basis, Other financing activities changed 0.0% to $29.3 million in Q1 2024 year-over-year; TTM through Mar 2024 was $29.3 million, a 0.0% change, with the full-year FY2025 number at -$291.9 million, down 2111.69% from a year prior.
  • Other financing activities hit $29.3 million in Q1 2024 for Universe Pharmaceuticals, roughly flat from $29.3 million in the prior quarter.
  • Over the last five years, Other financing activities for UPC hit a ceiling of $29279.2 billion in Q3 2021 and a floor of $29.3 million in Q1 2024.
  • Historically, Other financing activities has averaged $5493.0 billion across 5 years, with a median of $29.3 million in 2022.
  • Biggest five-year swings in Other financing activities: skyrocketed 695.85% in 2021 and later plummeted 100.0% in 2022.
  • Tracing UPC's Other financing activities over 5 years: stood at $3679.0 billion in 2020, then skyrocketed by 695.85% to $29279.2 billion in 2021, then plummeted by 100.0% to $29.3 million in 2022, then changed by 0.0% to $29.3 million in 2023, then fell by 0.0% to $29.3 million in 2024.
  • Business Quant data shows Other financing activities for UPC at $29.3 million in Q1 2024, $29.3 million in Q3 2023, and $29.3 million in Q1 2023.